Mammary Neoplasms, Experimental
"Mammary Neoplasms, Experimental" is a descriptor in the National Library of Medicine's controlled vocabulary thesaurus,
MeSH (Medical Subject Headings). Descriptors are arranged in a hierarchical structure,
which enables searching at various levels of specificity.
Experimentally induced mammary neoplasms in animals to provide a model for studying human BREAST NEOPLASMS.
| Descriptor ID |
D008325
|
| MeSH Number(s) |
C04.588.531.500 C04.619.590 E05.598.500.496.843
|
| Concept/Terms |
Mammary Neoplasms, Experimental- Mammary Neoplasms, Experimental
- Experimental Mammary Neoplasm
- Mammary Neoplasm, Experimental
- Neoplasm, Experimental Mammary
- Neoplasms, Experimental Mammary
- Experimental Mammary Neoplasms
|
Below are MeSH descriptors whose meaning is more general than "Mammary Neoplasms, Experimental".
Below are MeSH descriptors whose meaning is more specific than "Mammary Neoplasms, Experimental".
This graph shows the total number of publications written about "Mammary Neoplasms, Experimental" by people in this website by year, and whether "Mammary Neoplasms, Experimental" was a major or minor topic of these publications.
To see the data from this visualization as text,
click here.
| Year | Major Topic | Minor Topic | Total |
|---|
| 1993 | 1 | 0 | 1 |
| 1994 | 5 | 1 | 6 |
| 1995 | 1 | 1 | 2 |
| 1996 | 3 | 0 | 3 |
| 1997 | 4 | 0 | 4 |
| 1998 | 3 | 1 | 4 |
| 1999 | 0 | 1 | 1 |
| 2000 | 2 | 0 | 2 |
| 2001 | 1 | 1 | 2 |
| 2002 | 1 | 1 | 2 |
| 2004 | 1 | 0 | 1 |
| 2005 | 1 | 2 | 3 |
| 2006 | 4 | 0 | 4 |
| 2007 | 3 | 0 | 3 |
| 2008 | 1 | 0 | 1 |
| 2009 | 5 | 0 | 5 |
| 2010 | 2 | 0 | 2 |
| 2011 | 2 | 0 | 2 |
| 2012 | 1 | 0 | 1 |
| 2013 | 3 | 2 | 5 |
| 2014 | 4 | 0 | 4 |
| 2015 | 3 | 0 | 3 |
| 2016 | 3 | 0 | 3 |
| 2017 | 1 | 0 | 1 |
| 2018 | 1 | 1 | 2 |
| 2019 | 3 | 0 | 3 |
| 2021 | 2 | 0 | 2 |
To return to the timeline,
click here.
Below are the most recent publications written about "Mammary Neoplasms, Experimental" by people in Profiles.
-
All-trans retinoic acid and protein kinase C a/?1 inhibitor combined treatment targets cancer stem cells and impairs breast tumor progression. Sci Rep. 2021 03 15; 11(1):6044.
-
Prevention of mammary carcinogenesis in MMTV-neu mice by targeting RLIP. Mol Carcinog. 2021 03; 60(3):213-223.
-
The Lineage Determining Factor GRHL2 Collaborates with FOXA1 to Establish a Targetable Pathway in Endocrine Therapy-Resistant Breast Cancer. Cell Rep. 2019 10 22; 29(4):889-903.e10.
-
Modular imaging system: Rapid scan EPR at 800?MHz. J Magn Reson. 2019 08; 305:94-103.
-
Synergistic efficacy of RLIP inhibition and 2'-hydroxyflavanone against DMBA-induced mammary carcinogenesis in SENCAR mice. Mol Carcinog. 2019 08; 58(8):1438-1449.
-
Specific stereochemistry of OP-1074 disrupts estrogen receptor alpha helix 12 and confers pure antiestrogenic activity. Nat Commun. 2018 06 18; 9(1):2368.
-
A Role for Hypocretin/Orexin in Metabolic and Sleep Abnormalities in a Mouse Model of Non-metastatic Breast Cancer. Cell Metab. 2018 Jul 03; 28(1):118-129.e5.
-
Epimedin C Promotes Vascularization during BMP2-Induced Osteogenesis and Tumor-Associated Angiogenesis. Am J Chin Med. 2017; 45(5):1093-1111.
-
PTEN Loss in E-Cadherin-Deficient Mouse Mammary Epithelial Cells Rescues Apoptosis and Results in Development of Classical Invasive Lobular Carcinoma. Cell Rep. 2016 08 23; 16(8):2087-2101.
-
AhR ligand Aminoflavone inhibits a6-integrin expression and breast cancer sphere-initiating capacity. Cancer Lett. 2016 06 28; 376(1):53-61.